NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Forecast, Price & News $94.26 -1.82 (-1.89%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$93.92▼$97.9050-Day Range$84.96▼$116.3952-Week Range$82.51▼$140.23Volume478,643 shsAverage Volume380,230 shsMarket Capitalization$2.88 billionP/E RatioN/ADividend YieldN/APrice Target$139.22 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media iRhythm Technologies MarketRank™ ForecastAnalyst RatingModerate Buy2.78 Rating ScoreUpside/Downside47.7% Upside$139.22 Price TargetShort InterestBearish7.65% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.18) to ($2.30) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.99 out of 5 starsMedical Sector626th out of 972 stocksSurgical & Medical Instruments Industry69th out of 100 stocks 4.4 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $139.22, iRhythm Technologies has a forecasted upside of 47.7% from its current price of $94.26.Amount of Analyst CoverageiRhythm Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.65% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 0.43%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 2.5 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for iRhythm Technologies this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.MarketBeat Follows5 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.43% of the stock of iRhythm Technologies is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($3.18) to ($2.30) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -28.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -28.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 11.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About iRhythm Technologies (NASDAQ:IRTC) StockiRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More IRTC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRTC Stock News HeadlinesSeptember 29, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Stock Rating Upgraded by StockNews.comSeptember 27, 2023 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average Recommendation of "Moderate Buy" from AnalystsOctober 1, 2023 | Goldco (Ad)Biden's Digital Dollar NightmareOn July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted. You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again! Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late! September 26, 2023 | finance.yahoo.comiRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac MonitorSeptember 24, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Hits New 1-Year Low at $85.01September 22, 2023 | finance.yahoo.comUnveiling iRhythm Technologies (IRTC)'s Value: Is It Really Priced Right? A Comprehensive GuideSeptember 20, 2023 | finance.yahoo.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 33% Below Their Intrinsic Value EstimateAugust 29, 2023 | finance.yahoo.comiRhythm Technologies to Participate in Two Investor Conferences in SeptemberOctober 1, 2023 | Goldco (Ad)Biden's Digital Dollar NightmareOn July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted. You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again! Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late! August 29, 2023 | nasdaq.comCanaccord Genuity Maintains iRhythm Technologies (IRTC) Buy RecommendationAugust 9, 2023 | markets.businessinsider.comTruist Financial Remains a Buy on Irhythm Technologies (IRTC)August 7, 2023 | markets.businessinsider.comIRhythm Technologies' Cost Efficiency And Potential Entry Into The Japanese Market Earn Analyst ApplaudAugust 5, 2023 | markets.businessinsider.comStrong Zio AT Business Growth Propels iRhythm's Q2 Revenue Surge, Analysts Say Warning Letter ManageableAugust 4, 2023 | finance.yahoo.comIs iRhythm Technologies, Inc. (NASDAQ:IRTC) Potentially Undervalued?August 3, 2023 | finance.yahoo.comiRhythm Technologies Announces Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comZio Granted High Medical Needs Designation by the Japanese Ministry of Health, Labour, and WelfareAugust 3, 2023 | seekingalpha.comiRhythm Technologies, Inc. 2023 Q2 - Results - Earnings Call PresentationJuly 23, 2023 | markets.businessinsider.comTruist Financial Sticks to Their Buy Rating for Irhythm Technologies (IRTC)July 20, 2023 | finance.yahoo.comiRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023July 19, 2023 | msn.comBaird Initiates Coverage of iRhythm Technologies (IRTC) with Outperform RecommendationJuly 19, 2023 | msn.comiRhythm is a new Outperform at Baird despite FDA warning letterJuly 18, 2023 | finance.yahoo.comNAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service to Health Systems and PayersJuly 17, 2023 | markets.businessinsider.comIrhythm Technologies (IRTC) Gets a Buy from Truist FinancialJuly 16, 2023 | fool.comiRhythm Technologies (NASDAQ: IRTC)July 13, 2023 | msn.comiRhythm Technologies: Unpacking The FDA Warning LetterJuly 11, 2023 | msn.comMorgan Stanley Reiterates iRhythm Technologies (IRTC) Overweight RecommendationJuly 11, 2023 | markets.businessinsider.comWhat 11 Analyst Ratings Have To Say About iRhythm TechnologiesSee More Headlines Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Company Calendar Last Earnings8/03/2023Today10/01/2023Next Earnings (Estimated)11/07/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees1,793Year FoundedN/APrice Target and Rating Average Stock Price Forecast$139.22 High Stock Price Forecast$165.00 Low Stock Price Forecast$116.00 Forecasted Upside/Downside+47.7%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($3.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-116,150,000.00 Net Margins-21.95% Pretax Margin-21.84% Return on Equity-41.92% Return on Assets-22.28% Debt Debt-to-Equity Ratio0.16 Current Ratio2.71 Quick Ratio2.55 Sales & Book Value Annual Sales$410.92 million Price / Sales7.01 Cash FlowN/A Price / Cash FlowN/A Book Value$7.96 per share Price / Book11.84Miscellaneous Outstanding Shares30,580,000Free Float30,447,000Market Cap$2.88 billion OptionableOptionable Beta1.33 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Quentin S. Blackford (Age 44)Pres, CEO & Director Comp: $2.15MMr. Brice Bobzien CPA (Age 44)Chief Financial Officer Comp: $685.12kDr. Minang P. Turakhia M.D. (Age 49)M.S., Chief Medical & Scientific Officer and Exec. VP of Product Innovation Comp: $1MMr. Patrick Michael Murphy J.D. (Age 44)Chief Bus. & Legal Officer Comp: $1.28MMr. Douglas J. Devine (Age 53)Exec. Advisor Comp: $800kMr. Chad M. Patterson (Age 41)Chief Commercial Officer Comp: $771.51kMr. Marc Rosenbaum (Age 51)Sr. VP of Fin. & Chief Accounting Officer Mr. Mark J. Day Ph.D. (Age 52)Chief Technology Officer Mr. Daniel G. Wilson (Age 40)Exec. VP of Corp. Devel. & Investor Relations Ms. Sumi Shrishrimal (Age 44)Exec. VP & Chief Risk Officer More ExecutivesKey CompetitorsICU MedicalNASDAQ:ICUIAxonicsNASDAQ:AXNXIntegra LifeSciencesNASDAQ:IARTAtriCureNASDAQ:ATRCNovoCureNASDAQ:NVCRView All CompetitorsInsiders & InstitutionsBarclays PLCSold 27,855 shares on 9/21/2023Ownership: 0.066%Wolverine Trading LLCBought 3,300 shares on 8/23/2023Ownership: 0.000%Comerica BankBought 14,034 shares on 8/22/2023Ownership: 0.046%California State Teachers Retirement SystemSold 661 shares on 8/21/2023Ownership: 0.121%Osaic Holdings Inc.Sold 712 shares on 8/21/2023Ownership: 0.006%View All Insider TransactionsView All Institutional Transactions IRTC Stock - Frequently Asked Questions Should I buy or sell iRhythm Technologies stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" IRTC shares. View IRTC analyst ratings or view top-rated stocks. What is iRhythm Technologies' stock price forecast for 2023? 9 Wall Street research analysts have issued 12 month price targets for iRhythm Technologies' stock. Their IRTC share price forecasts range from $116.00 to $165.00. On average, they anticipate the company's stock price to reach $139.22 in the next twelve months. This suggests a possible upside of 47.7% from the stock's current price. View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts. How have IRTC shares performed in 2023? iRhythm Technologies' stock was trading at $93.67 at the beginning of the year. Since then, IRTC shares have increased by 0.6% and is now trading at $94.26. View the best growth stocks for 2023 here. When is iRhythm Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023. View our IRTC earnings forecast. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) posted its quarterly earnings data on Thursday, August, 3rd. The company reported ($0.61) earnings per share for the quarter, beating analysts' consensus estimates of ($0.75) by $0.14. The firm earned $124.13 million during the quarter, compared to the consensus estimate of $120.03 million. iRhythm Technologies had a negative net margin of 21.95% and a negative trailing twelve-month return on equity of 41.92%. What ETFs hold iRhythm Technologies' stock? ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Robotics & Automation ETF (ROBO), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), BNY Mellon Innovators ETF (BKIV) and Fidelity Disruptive Medicine ETF (FMED). What guidance has iRhythm Technologies issued on next quarter's earnings? iRhythm Technologies updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $485.00 million-$490.00 million, compared to the consensus revenue estimate of $483.78 million. What is Kevin M. King's approval rating as iRhythm Technologies' CEO? 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA). When did iRhythm Technologies IPO? (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What is iRhythm Technologies' stock symbol? iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC." How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iRhythm Technologies' stock price today? One share of IRTC stock can currently be purchased for approximately $94.26. How much money does iRhythm Technologies make? iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $2.88 billion and generates $410.92 million in revenue each year. The company earns $-116,150,000.00 in net income (profit) each year or ($3.28) on an earnings per share basis. How many employees does iRhythm Technologies have? The company employs 1,793 workers across the globe. How can I contact iRhythm Technologies? iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com. This page (NASDAQ:IRTC) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.